NYSE:ZTS - Zoetis Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$84.00 -0.38 (-0.45 %)
(As of 05/23/2018 12:20 PM ET)
Previous Close$84.30
Today's Range$83.75 - $84.39
52-Week Range$59.50 - $86.38
Volume62,971 shs
Average Volume2.73 million shs
Market Capitalization$41.31 billion
P/E Ratio35.10
Dividend Yield0.59%
Beta0.97

About Zoetis (NYSE:ZTS)

Zoetis logoZoetis Inc. discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. In addition, the company offers other product categories, including nutritionals and agribusiness services, as well as products and services in complementary areas, such as biodevices, diagnostics, and genetics. It markets its products to veterinarians, livestock producers, and people who raise and care for farm and companion animals through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Receive ZTS News and Ratings via Email

Sign-up to receive the latest news and ratings for ZTS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNYSE:ZTS
CUSIP98978V10
Phone973-822-7000

Debt

Debt-to-Equity Ratio2.51
Current Ratio4.27
Quick Ratio2.83

Price-To-Earnings

Trailing P/E Ratio35.10
Forward P/E Ratio27.45
P/E Growth1.88

Sales & Book Value

Annual Sales$5.31 billion
Price / Sales7.66
Cash Flow$2.8807 per share
Price / Cash29.16
Book Value$4.08 per share
Price / Book20.59

Profitability

EPS (Most Recent Fiscal Year)$2.40
Net Income$864 million
Net Margins17.97%
Return on Equity68.51%
Return on Assets15.00%

Miscellaneous

Employees9,200
Outstanding Shares483,860,000

Zoetis (NYSE:ZTS) Frequently Asked Questions

What is Zoetis' stock symbol?

Zoetis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS."

How often does Zoetis pay dividends? What is the dividend yield for Zoetis?

Zoetis announced a quarterly dividend on Tuesday, May 15th. Investors of record on Friday, July 20th will be paid a dividend of $0.126 per share on Tuesday, September 4th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date of this dividend is Thursday, July 19th. View Zoetis' Dividend History.

How were Zoetis' earnings last quarter?

Zoetis (NYSE:ZTS) posted its quarterly earnings results on Wednesday, May, 2nd. The company reported $0.75 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.69 by $0.06. The business earned $1.37 billion during the quarter, compared to analyst estimates of $1.35 billion. Zoetis had a return on equity of 68.51% and a net margin of 17.97%. Zoetis's revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.53 EPS. View Zoetis' Earnings History.

When is Zoetis' next earnings date?

Zoetis is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Zoetis.

What guidance has Zoetis issued on next quarter's earnings?

Zoetis updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share guidance of $2.96-3.10 for the period, compared to the Thomson Reuters consensus estimate of $3.04. The company issued revenue guidance of $5.675-5.800 billion, compared to the consensus revenue estimate of $5.74 billion.

What price target have analysts set for ZTS?

18 brokerages have issued twelve-month target prices for Zoetis' shares. Their predictions range from $62.00 to $98.00. On average, they expect Zoetis' share price to reach $82.6471 in the next twelve months. View Analyst Ratings for Zoetis.

What are Wall Street analysts saying about Zoetis stock?

Here are some recent quotes from research analysts about Zoetis stock:
  • 1. Cantor Fitzgerald analysts commented, "We rate ZTS as 12-month price target of $98. Given the company’s durable business model and the positive outlook for macro factors, we think the multiple will hold and upwards earnings revisions should drive shares higher. Valuation Summary We use a blend of DCF and multiples analysis (EV/EBITDA) to get to our 12- month price target of $98." (5/16/2018)
  • 2. According to Zacks Investment Research, "Zoetis faces stiff competition from other animal health medicines and vaccines companies like Merck Animal Health (the animal health division of Merck), Elanco (the animal health division of Eli Lilly), Bayer Animal Health (the animal health division of Bayer) and Boehringer Ingelheim Animal Health (the animal health division of Boehringer Ingelheim). Disease outbreak among animals is a material cause of concern for Zoetis’ livestock products.In addition, companion animal health products are often directly prescribed and dispensed by veterinarians. The swine business is being impacted by competition for Fostera. These competitive pressures could adversely affect the company’s business and operating results. However, shares of the company have outperformed the industry in the last six months." (1/13/2018)

Who are some of Zoetis' key competitors?

Who are Zoetis' key executives?

Zoetis' management team includes the folowing people:
  • Mr. Juan Ramón Alaix, CEO & Director (Age 67)
  • Mr. Glenn C. David, Exec. VP & CFO (Age 46)
  • Dr. Catherine A. Knupp, Exec. VP and Pres of R&D (Age 57)
  • Mr. Clinton A. Lewis Jr., EVP and Pres of International Ops., Commercial Devel., Global Genetics & Aquatic Health (Age 51)
  • Ms. Kristin C. Peck, Exec. VP and Group Pres of U.S. Operations, Bus. Devel. & Strategy (Age 47)

Has Zoetis been receiving favorable news coverage?

Media headlines about ZTS stock have been trending somewhat positive recently, Accern reports. Accern rates the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Zoetis earned a news sentiment score of 0.17 on Accern's scale. They also assigned news headlines about the company an impact score of 47.97 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are Zoetis' major shareholders?

Zoetis' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.49%), Polen Capital Management LLC (1.85%), Massachusetts Financial Services Co. MA (1.66%), Northern Trust Corp (1.23%), Wells Fargo & Company MN (1.20%) and American Century Companies Inc. (1.07%). Company insiders that own Zoetis stock include Andrew Fenton, Catherine A Knupp, Heidi C Chen, Kristin C Peck, Michael B Mccallister, Roman Trawicki and Roxanne Lagano. View Institutional Ownership Trends for Zoetis.

Which major investors are selling Zoetis stock?

ZTS stock was sold by a variety of institutional investors in the last quarter, including Independent Franchise Partners LLP, Winslow Capital Management LLC, Thrivent Financial for Lutherans, Eaton Vance Management, Cantillon Capital Management LLC, Massachusetts Financial Services Co. MA, Federated Investors Inc. PA and Franklin Resources Inc.. Company insiders that have sold Zoetis company stock in the last year include Heidi C Chen, Kristin C Peck, Roman Trawicki and Roxanne Lagano. View Insider Buying and Selling for Zoetis.

Which major investors are buying Zoetis stock?

ZTS stock was bought by a variety of institutional investors in the last quarter, including Polen Capital Management LLC, BlackRock Inc., Amundi Pioneer Asset Management Inc., Royal Bank of Canada, Wells Fargo & Company MN, Intermede Investment Partners Ltd, Prudential Financial Inc. and Westfield Capital Management Co. LP. View Insider Buying and Selling for Zoetis.

How do I buy shares of Zoetis?

Shares of ZTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zoetis' stock price today?

One share of ZTS stock can currently be purchased for approximately $84.00.

How big of a company is Zoetis?

Zoetis has a market capitalization of $41.31 billion and generates $5.31 billion in revenue each year. The company earns $864 million in net income (profit) each year or $2.40 on an earnings per share basis. Zoetis employs 9,200 workers across the globe.

How can I contact Zoetis?

Zoetis' mailing address is 10 Sylvan Way, Parsippany NJ, 07054. The company can be reached via phone at 973-822-7000 or via email at [email protected]


MarketBeat Community Rating for Zoetis (ZTS)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  522 (Vote Outperform)
Underperform Votes:  311 (Vote Underperform)
Total Votes:  833
MarketBeat's community ratings are surveys of what our community members think about Zoetis and other stocks. Vote "Outperform" if you believe ZTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZTS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Zoetis (NYSE:ZTS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
18 Wall Street analysts have issued ratings and price targets for Zoetis in the last 12 months. Their average twelve-month price target is $82.6471, suggesting that the stock has a possible downside of 1.61%. The high price target for ZTS is $98.00 and the low price target for ZTS is $62.00. There are currently 7 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.612.612.722.59
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $82.6471$81.5294$79.6471$67.4375
Price Target Upside: 1.61% downside5.17% downside0.10% downside5.11% downside

Zoetis (NYSE:ZTS) Consensus Price Target History

Price Target History for Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2018BMO Capital MarketsReiterated RatingHold$80.00LowView Rating Details
5/16/2018Cantor FitzgeraldReiterated RatingBuy$98.00LowView Rating Details
4/25/2018Craig HallumReiterated RatingBuy$87.00 ➝ $94.00LowView Rating Details
4/19/2018Hilliard LyonsDowngradeNeutralLowView Rating Details
4/19/2018CitigroupReiterated RatingBuy ➝ Buy$85.00 ➝ $98.00LowView Rating Details
4/13/2018Jefferies GroupReiterated RatingBuy$96.00LowView Rating Details
4/5/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$83.00 ➝ $89.00LowView Rating Details
3/19/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$70.00LowView Rating Details
2/17/2018BarclaysSet Price TargetHold$77.00MediumView Rating Details
2/16/2018Deutsche BankBoost Price TargetHold ➝ Hold$76.00 ➝ $78.00LowView Rating Details
2/16/2018Piper Jaffray CompaniesSet Price TargetBuy$88.00LowView Rating Details
2/16/2018Stifel NicolausReiterated RatingBuy ➝ Buy$84.00 ➝ $86.00MediumView Rating Details
2/16/2018Bank of AmericaBoost Price TargetBuy$80.00 ➝ $87.00MediumView Rating Details
2/15/2018CowenSet Price TargetBuy$85.00MediumView Rating Details
11/24/2017UBSReiterated RatingBuy ➝ NeutralN/AView Rating Details
8/7/2017Goldman SachsReiterated RatingNeutral ➝ Neutral$62.00LowView Rating Details
5/30/2017ArgusReiterated RatingBuy$60.00 ➝ $69.00LowView Rating Details
5/26/2017CL KingInitiated CoverageBuy ➝ Buy$71.00LowView Rating Details
2/16/2017GuggenheimBoost Price TargetBuy$60.00 ➝ $65.00N/AView Rating Details
2/16/2017Off Wall StreetReiterated RatingStrong Sell$35.00N/AView Rating Details
11/3/2016JPMorgan ChaseReiterated RatingHold$53.00N/AView Rating Details
(Data available from 5/23/2016 forward)

Earnings

Zoetis (NYSE:ZTS) Earnings History and Estimates Chart

Earnings by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) Earnings Estimates

2018 EPS Consensus Estimate: $3.03
2019 EPS Consensus Estimate: $3.37
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.70$0.71$0.71
Q2 20181$0.72$0.72$0.72
Q3 20181$0.78$0.78$0.78
Q4 20181$0.82$0.82$0.82
Q1 20191$0.78$0.78$0.78
Q2 20191$0.80$0.80$0.80
Q3 20191$0.88$0.88$0.88
Q4 20191$0.91$0.91$0.91

Zoetis (NYSE ZTS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/6/2018$0.71N/AView Earnings Details
5/2/2018Q1 2018$0.69$0.75$1.3473 billion$1.3660 billionViewN/AView Earnings Details
2/15/2018Q4 2017$0.66$0.69$1.4034 billion$1.46 billionViewN/AView Earnings Details
11/2/2017Q3 2017$0.63$0.65$1.3206 billion$1.3470 billionViewN/AView Earnings Details
8/8/2017Q2 2017$0.53$0.5280$1.2660 billion$1.2690 billionViewListenView Earnings Details
5/4/2017Q1 2017$0.48$0.53$1.1967 billion$1.2310 billionViewListenView Earnings Details
2/16/2017Q416$0.45$0.47$1.28 billion$1.30 billionViewN/AView Earnings Details
11/2/2016Q316$0.46$0.52$1.22 billion$1.20 billionViewN/AView Earnings Details
8/3/2016Q216$0.44$0.49$1.17 billion$1.20 billionViewN/AView Earnings Details
5/4/2016Q116$0.41$0.48$1.10 billion$1.20 billionViewN/AView Earnings Details
2/16/2016Q415$0.39$0.43$1.25 billion$1.30 billionViewListenView Earnings Details
11/3/2015Q315$0.40$0.50$1.18 billion$1.20 billionViewN/AView Earnings Details
8/4/2015Q215$0.38$0.43$1.12 billion$1.20 billionViewN/AView Earnings Details
5/5/2015Q115$0.37$0.41$1.11 billion$1.10 billionViewN/AView Earnings Details
2/11/2015Q414$0.36$0.40$1.27 billion$1.30 billionViewN/AView Earnings Details
11/4/2014Q314$0.37$0.41$1.16 billion$1.20 billionViewN/AView Earnings Details
8/5/2014Q2 2014$0.39$0.38$1.1640 billion$1.1580 billionViewN/AView Earnings Details
5/6/2014Q114$0.37$0.38$1.13 billion$1.10 billionViewN/AView Earnings Details
2/11/2014Q413$0.34$0.36$1.21 billion$1.25 billionViewN/AView Earnings Details
11/5/2013Q313$0.34$0.34$1.07 billion$1.10 billionViewN/AView Earnings Details
8/6/2013Q2 2013$0.36$0.36$1.13 billion$1.1140 billionViewN/AView Earnings Details
4/30/2013Q1 2013$0.27$0.36$1.24 billion$1.09 billionViewN/AView Earnings Details
3/28/2013Q4 2012$0.34$0.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Zoetis (NYSE:ZTS) Dividend Information

Zoetis pays an annual dividend of $0.50 per share, with a dividend yield of 0.60%. ZTS's next quarterly dividend payment will be made on Tuesday, September 4. The company has grown its dividend for the last 4 consecutive years and is increasing its dividend by an average of 13.40% each year. Zoetis pays out 20.83% of its earnings out as a dividend.
Next Dividend:9/4/2018
Annual Dividend:$0.50
Dividend Yield:0.60%
Dividend Growth:13.40% (3 Year Average)
Payout Ratio(s):20.83% (Trailing 12 Months of Earnings)
16.34% (Based on This Year's Estimates)
14.53% (Based on Next Year's Estimates)
17.36% (Based on Cash Flow)
Track Record:4 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE:ZTS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2018quarterly$0.12600.6%7/19/20187/20/20189/4/2018
2/14/2018quarterly$0.12600.68%4/19/20184/20/20186/1/2018
12/12/2017quarterly$0.12600.7%1/18/20181/19/20183/1/2018
10/5/2017quarterly$0.10500.66%11/8/201711/9/201712/1/2017
5/12/2017quarterly$0.10500.7%6/13/20176/15/20179/1/2017
2/15/2017quarterly$0.10500.76%4/4/20174/6/20176/1/2017
12/6/2016quarterly$0.10500.82%1/18/20171/20/20173/1/2017
10/7/2016quarterly$0.09500.73%11/1/201611/3/201612/1/2016
5/13/2016quarterly$0.09500.82%6/28/20166/30/20168/30/2016
2/22/2016quarterly$0.09500.89%4/5/20164/7/20166/1/2016
12/17/2015quarterly$0.09500.81%1/19/20161/21/20163/1/2016
10/2/2015quarterly$0.08300.77%11/3/201511/5/201512/1/2015
7/22/2015quarterly$0.08300.66%8/11/20158/13/20159/1/2015
3/2/2015quarterly$0.08300.7%4/7/20154/9/20156/2/2015
12/18/2014quarterly$0.08300.77%1/20/20151/22/20153/3/2015
10/2/2014quarterly$0.07200.76%11/3/201411/5/201412/2/2014
7/31/2014quarterly$0.07200.88%8/18/20148/20/20149/2/2014
3/26/2014quarterly$0.07200.98%4/23/20144/27/20146/2/2014
12/19/2013quarterly$0.07200.89%1/28/20141/30/20143/4/2014
9/12/2013quarterly$0.06500.84%10/30/201311/1/201312/2/2013
6/20/2013quarterly$0.06508/1/20139/2/2013
3/29/2013special$0.06504/29/20135/1/20136/6/2013
3/28/2013quarterly$0.06505/1/20136/6/2013
(Data available from 1/1/2013 forward)

Insider Trades

Zoetis (NYSE ZTS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.35%
Institutional Ownership Percentage: 91.15%
Insider Trading History for Zoetis (NYSE:ZTS)
Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Zoetis (NYSE ZTS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/1/2018Kristin C PeckInsiderSell4,877$83.46$407,034.4242,652View SEC Filing  
3/16/2018Heidi C ChenInsiderSell7,383$84.71$625,413.9320,162View SEC Filing  
3/9/2018Roman TrawickiInsiderSell8,568$83.10$712,000.8011,457View SEC Filing  
2/23/2018Roman TrawickiInsiderSell23,885$82.00$1,958,570.00View SEC Filing  
2/21/2018Roxanne LaganoEVPSell35,663$81.02$2,889,416.2649,919View SEC Filing  
2/20/2018Heidi C ChenInsiderSell37,453$81.02$3,034,442.06View SEC Filing  
5/12/2017Catherine A KnuppInsiderSell5,785$60.16$348,025.6024,415View SEC Filing  
11/22/2016Kristin C PeckInsiderSell10,092$49.55$500,058.6022,768View SEC Filing  
11/8/2016Roxanne LaganoInsiderSell9,797$50.43$494,062.718,063View SEC Filing  
9/6/2016Michael B MccallisterDirectorBuy2,000$51.34$102,680.00View SEC Filing  
9/2/2016Andrew FentonInsiderSell13,870$51.25$710,837.5017,719View SEC Filing  
9/1/2016Heidi C ChenInsiderSell32,097$50.98$1,636,305.0646,060View SEC Filing  
5/9/2016Pershing Square Capital ManageDirectorSell16,850,000$46.55$784,367,500.00View SEC Filing  
8/8/2013Michael MccallisterDirectorBuy7,000$31.35$219,450.00View SEC Filing  
2/6/2013Frank A DamelioDirectorBuy5,000$26.00$130,000.00View SEC Filing  
2/6/2013Sandra J BeatyEVPBuy2,000$26.00$52,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Zoetis (NYSE ZTS) News Headlines

Source:
DateHeadline
Is Zoetis Inc’s (NYSE:ZTS) 49.27% ROE Strong Compared To Its Industry?Is Zoetis Inc’s (NYSE:ZTS) 49.27% ROE Strong Compared To Its Industry?
finance.yahoo.com - May 23 at 9:21 AM
FY2018 Earnings Estimate for Zoetis (ZTS) Issued By Cantor FitzgeraldFY2018 Earnings Estimate for Zoetis (ZTS) Issued By Cantor Fitzgerald
www.americanbankingnews.com - May 23 at 7:05 AM
Zoetis to Participate in the Stifel 2018 Dental & Veterinary ConferenceZoetis to Participate in the Stifel 2018 Dental & Veterinary Conference
www.businesswire.com - May 22 at 9:28 AM
Zoetis Agrees To Buy Abaxis In $2.0 Bln DealZoetis Agrees To Buy Abaxis In $2.0 Bln Deal
www.nasdaq.com - May 18 at 10:58 AM
Zoetis Inc. (ZTS) PT Raised to $82 at BMO Capital; Abaxis Deal Strong But Doesnt Change ThesisZoetis Inc. (ZTS) PT Raised to $82 at BMO Capital; Abaxis Deal Strong But Doesn't Change Thesis
www.streetinsider.com - May 17 at 4:14 PM
Abaxis (ABAX) to be Acquired by Zoetis, Shares All-Time HighAbaxis (ABAX) to be Acquired by Zoetis, Shares All-Time High
finance.yahoo.com - May 17 at 4:14 PM
Company News For May 17, 2018Company News For May 17, 2018
finance.yahoo.com - May 17 at 4:14 PM
[$$] Zoetis to Buy Veterinary-Diagnostics Company Abaxis for $2 Billion[$$] Zoetis to Buy Veterinary-Diagnostics Company Abaxis for $2 Billion
finance.yahoo.com - May 17 at 9:52 AM
Zoetis (ZTS) Expected to Announce Quarterly Sales of $1.39 BillionZoetis (ZTS) Expected to Announce Quarterly Sales of $1.39 Billion
www.americanbankingnews.com - May 17 at 4:52 AM
Zoetis (ZTS) Receives "Hold" Rating from BMO Capital MarketsZoetis (ZTS) Receives "Hold" Rating from BMO Capital Markets
www.americanbankingnews.com - May 16 at 4:50 PM
Dow Closes Higher as Wall Street Weighs Rising RatesDow Closes Higher as Wall Street Weighs Rising Rates
finance.yahoo.com - May 16 at 4:20 PM
Zoetis Inc. -- Moodys says Zoetis acquisition of Abaxis is credit negativeZoetis Inc. -- Moody's says Zoetis' acquisition of Abaxis is credit negative
finance.yahoo.com - May 16 at 4:20 PM
Zoetis (ZTS) Rating Reiterated by Cantor FitzgeraldZoetis (ZTS) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - May 16 at 3:21 PM
M&A News: Abaxis Inc Shares Soar on $2 Billion Zoetis DealM&A News: Abaxis Inc Shares Soar on $2 Billion Zoetis Deal
investorplace.com - May 16 at 12:21 PM
M&A News: Abaxis Inc Shares Soar on $2 Billion Zoetis DealM&A News: Abaxis Inc Shares Soar on $2 Billion Zoetis Deal
investorplace.com - May 16 at 12:18 PM
BRIEF-Zoetis To Acquire Abaxis for about $2 Bln In AggregateBRIEF-Zoetis To Acquire Abaxis for about $2 Bln In Aggregate
www.reuters.com - May 16 at 10:10 AM
Zoetis Declares Third Quarter 2018 DividendZoetis Declares Third Quarter 2018 Dividend
www.businesswire.com - May 16 at 10:10 AM
Stocks Trade Modestly Higher Amid Rising RatesStocks Trade Modestly Higher Amid Rising Rates
finance.yahoo.com - May 16 at 10:10 AM
Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billionZoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion
www.cnbc.com - May 16 at 8:10 AM
Zoetis to acquire Abaxis for $2BZoetis to acquire Abaxis for $2B
seekingalpha.com - May 16 at 7:52 AM
Zoetis (ZTS) Declares Quarterly Dividend of $0.13Zoetis (ZTS) Declares Quarterly Dividend of $0.13
www.americanbankingnews.com - May 15 at 5:58 PM
BRIEF-Anatara Lifesciences Announces Exclusive Global License Agreement With ZoetisBRIEF-Anatara Lifesciences Announces Exclusive Global License Agreement With Zoetis
www.reuters.com - May 15 at 10:15 AM
Anatara Announces Exclusive Global License Agreement with ZoetisAnatara Announces Exclusive Global License Agreement with Zoetis
www.businesswire.com - May 15 at 10:15 AM
$0.71 Earnings Per Share Expected for Zoetis (ZTS) This Quarter$0.71 Earnings Per Share Expected for Zoetis (ZTS) This Quarter
www.americanbankingnews.com - May 15 at 3:26 AM
Zoetis Reaches Analyst Target PriceZoetis Reaches Analyst Target Price
www.forbes.com - May 14 at 4:18 PM
Head to Head Contrast: Zoetis (ZTS) and Its RivalsHead to Head Contrast: Zoetis (ZTS) and Its Rivals
www.americanbankingnews.com - May 13 at 5:15 PM
Critical Contrast: Zoetis (ZTS) vs. The CompetitionCritical Contrast: Zoetis (ZTS) vs. The Competition
www.americanbankingnews.com - May 13 at 3:16 AM
Zoetis (ZTS) Expected to Post Q4 2018 Earnings of $0.82 Per ShareZoetis (ZTS) Expected to Post Q4 2018 Earnings of $0.82 Per Share
www.americanbankingnews.com - May 7 at 4:16 AM
Research Analysts Set Expectations for Zoetis Q3 2018 Earnings (ZTS)Research Analysts Set Expectations for Zoetis' Q3 2018 Earnings (ZTS)
www.americanbankingnews.com - May 4 at 7:26 AM
Kristin C. Peck Sells 4,877 Shares of Zoetis (ZTS) StockKristin C. Peck Sells 4,877 Shares of Zoetis (ZTS) Stock
www.americanbankingnews.com - May 3 at 7:54 PM
Edited Transcript of ZTS earnings conference call or presentation 2-May-18 12:30pm GMTEdited Transcript of ZTS earnings conference call or presentation 2-May-18 12:30pm GMT
finance.yahoo.com - May 3 at 9:35 AM
Zoetis Inc.Zoetis Inc.
www.streetinsider.com - May 2 at 4:18 PM
Zoetis (ZTS) Beats on Q1 Earnings & Sales, Retains 18 ViewZoetis (ZTS) Beats on Q1 Earnings & Sales, Retains '18 View
www.zacks.com - May 2 at 4:18 PM
Zoetis (ZTS) Beats on Q1 Earnings & Sales, Retains '18 ViewZoetis (ZTS) Beats on Q1 Earnings & Sales, Retains '18 View
finance.yahoo.com - May 2 at 4:18 PM
Zoetis (ZTS) Posts  Earnings ResultsZoetis (ZTS) Posts Earnings Results
www.americanbankingnews.com - May 2 at 11:42 AM
BRIEF-Zoetis Announces Q1 Earnings Per Share $0.72BRIEF-Zoetis Announces Q1 Earnings Per Share $0.72
www.reuters.com - May 2 at 9:37 AM
Zoetis profit up 48%, buoyed by tax benefitZoetis profit up 48%, buoyed by tax benefit
www.marketwatch.com - May 2 at 9:37 AM
Zoetis Tops Quarterly Estimates But 2018 Earnings View Soft At MidpointZoetis Tops Quarterly Estimates But 2018 Earnings View Soft At Midpoint
finance.yahoo.com - May 2 at 9:37 AM
Zoetis: 1Q Earnings SnapshotZoetis: 1Q Earnings Snapshot
finance.yahoo.com - May 2 at 9:37 AM
Zoetis (ZTS) Updates FY18 Earnings GuidanceZoetis (ZTS) Updates FY18 Earnings Guidance
www.americanbankingnews.com - May 2 at 9:15 AM
Zoetis Q1 revenues up 11%; non-GAAP EPS up 42%; reiterates guidanceZoetis Q1 revenues up 11%; non-GAAP EPS up 42%; reiterates guidance
seekingalpha.com - May 2 at 8:55 AM
Zoetis (ZTS) call put ratio 1 call to 6 puts into Q1Zoetis (ZTS) call put ratio 1 call to 6 puts into Q1
www.streetinsider.com - May 1 at 4:14 PM
Forbes Names Zoetis One of America’s Best Employers for Third Year in a RowForbes Names Zoetis One of America’s Best Employers for Third Year in a Row
finance.yahoo.com - May 1 at 4:13 PM
Zoetis (ZTS) Given a $90.00 Price Target by Cantor Fitzgerald AnalystsZoetis (ZTS) Given a $90.00 Price Target by Cantor Fitzgerald Analysts
www.americanbankingnews.com - May 1 at 10:01 AM
Zoetis (ZTS) Receives Consensus Recommendation of "Buy" from BrokeragesZoetis (ZTS) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 30 at 3:40 PM
Zoetis (ZTS) Gears Up for Q1 Earnings: Whats in Store?Zoetis (ZTS) Gears Up for Q1 Earnings: What's in Store?
www.nasdaq.com - April 30 at 10:40 AM
Zoetis (ZTS) Gears Up for Q1 Earnings: What's in Store?Zoetis (ZTS) Gears Up for Q1 Earnings: What's in Store?
finance.yahoo.com - April 30 at 10:39 AM
Zacks: Brokerages Anticipate Zoetis (ZTS) Will Post Quarterly Sales of $1.33 BillionZacks: Brokerages Anticipate Zoetis (ZTS) Will Post Quarterly Sales of $1.33 Billion
www.americanbankingnews.com - April 29 at 2:52 AM
Zacks: Brokerages Expect Zoetis (ZTS) to Announce $0.70 EPSZacks: Brokerages Expect Zoetis (ZTS) to Announce $0.70 EPS
www.americanbankingnews.com - April 27 at 3:18 PM
BRIEF-Zoetis Inc To Expand Animal Vaccine Research And Manufacturing In Suzhou, ChinaBRIEF-Zoetis Inc To Expand Animal Vaccine Research And Manufacturing In Suzhou, China
www.reuters.com - April 26 at 9:41 AM

SEC Filings

Zoetis (NYSE:ZTS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Zoetis (NYSE:ZTS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Zoetis (NYSE ZTS) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.